Expect continued selling pressure as the registration becomes effective. Monitor for any Put Notices under the ELOC — each put could push the stock lower. The company's weak financial position (EBITDA negative, large debt) makes it likely they will tap the ELOC, accelerating dilution.
Executive Summary
Synergy CHC filed an S-1 registration for the resale of up to 101.71 million shares by selling stockholder Hudson Global Ventures, tied to an ELOC agreement that could provide up to $36M in gross proceeds to the company. The filing comes as the company reports a sharp deterioration in financials: revenue declined 12.6% to $30.4M in FY2025, net income swung from $2.1M profit to a $12.3M loss, and EBITDA collapsed from $6.5M to negative $6.2M. The massive potential dilution (up to 6.8x current shares outstanding) combined with worsening fundamentals creates a significant bearish overhang.
Key Financial Metrics
Key Facts
- Revenue fell from $34.8M (FY2024) to $30.4M (FY2025), a 12.6% decline.
- Net income swung from +$2.1M to -$12.3M; EBITDA turned from +$6.5M to -$6.2M.
- Registration covers 101.71M shares vs. 14.9M outstanding — potential dilution of ~683%.
- ELOC allows company to sell up to $36M of stock to Hudson Global at 95% of market price.
- Selling stockholder deemed an underwriter; company receives no proceeds from resale.
- Exchange cap of 19.99% without shareholder approval limits near-term dilution.
- Company is a smaller reporting company with $4M market cap and $0.30 stock price.
Financial Impact
Revenue decline of $4.4M (-12.6%), net income swing of -$14.5M, and potential dilution of up to 101.7M shares (if ELOC fully drawn).
Risk Factors
- Further revenue decline and inability to return to profitability.
- Massive dilution from ELOC draws could crush stock price.
- Potential delisting if Nasdaq minimum bid price rule is not met.
- Highly levered balance sheet with interest expense of $5.9M in FY2025.
- Concentration risk: 92% of revenue from FOCUSfactor brand.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-1 Filing (Primary) | 0001213900-26-057939 |
| Document: ea029095401ex-fee.htm | 0001213900-26-057939 |
| Document: ea029095401ex5-1.htm | 0001213900-26-057939 |
| Document: ea029095401ex23-1.htm | 0001213900-26-057939 |
| Document: 0001213900-26-057939-index-headers.html | 0001213900-26-057939 |
| Document: 0001213900-26-057939-index.html | 0001213900-26-057939 |
| Document: 0001213900-26-057939.txt | 0001213900-26-057939 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 16, 2026 5w ago | 8-K | $0.0905 | awaiting T+20 | — | — |
Aug 26, 2026 8w ago | 8-K | $0.0980 | awaiting T+20 | — | — |
Aug 21, 2026 9w ago | 8-K | $0.1009 $0.0905 | ▲ +10.31% | ▲ +9.78% | — |
Aug 21, 2026 9w ago | Press Release | $0.1009 $0.0905 | ▲ +10.31% | ▲ +9.78% | — |
Jun 29, 2026 17w ago | 8-K | $0.1985 $0.1679 | ▲ +15.42% | ▲ +14.39% | — |
May 26, 2026 22w ago | EFFECT | $0.2650 $0.2150 | ▲ +18.87% | ▲ +16.92% | — |
May 18, 2026 23w ago | 8-K | $0.2760 $0.1941 | ▲ +29.67% | ▲ +31.26% | — |
May 15, 2026 23w ago | S-1 | $0.2760 $0.1941 | ▲ +29.67% | ▲ +31.26% | — |
May 14, 2026 23w ago | 8-K | $0.2750 $0.1960 | ▲ +28.73% | ▲ +27.87% | — |
May 14, 2026 23w ago | Press Release | $0.2750 $0.1960 | ▲ +28.73% | ▲ +27.87% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers